| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/20/1983 | EP0076870A1 Process for the preparation of highly purified antihemophilic factor |
| 04/20/1983 | EP0076818A1 Peptides with nerve-regenerating properties |
| 04/19/1983 | US4380535 Peptides |
| 04/19/1983 | US4380511 Anthraquinone dyes, dextran |
| 04/14/1983 | WO1983001251A1 Polypeptide, preparation method thereof, utilization thereof and pharmaceutical products containing it |
| 04/14/1983 | WO1983001198A1 Method and composition for treating a patient suffering from interferon-susceptible disorder |
| 04/13/1983 | EP0076676A2 Process for using endorphins as antitumour agents |
| 04/13/1983 | EP0076557A2 Peptides and pseudopeptides in which the N terminus bears two substituents |
| 04/13/1983 | EP0076489A2 Deoxyribonucleic acids, recombinant deoxyribonucleic acids, hosts containing them, polypeptides and process for their production |
| 04/12/1983 | CA1144480A1 Stabilized parenterally administrable solutions |
| 04/06/1983 | EP0075925A2 Process for producing an active ingredient specifically acting upon the nutritive centre as an appetizer, and the active ingredient obtained by the process |
| 04/06/1983 | EP0075895A2 Pharmaceutical amides, and preparation, formulations and use thereof |
| 04/06/1983 | EP0075776A1 Bis-thymosine alpha-1 compounds |
| 04/06/1983 | EP0075604A1 Blood glucose level-lowering agent |
| 04/05/1983 | US4379146 Substituted phosphonamides as antihypertensives |
| 04/05/1983 | US4379142 Thrombin inhibitor and preparation and use thereof |
| 04/05/1983 | US4379087 Method of preparing alpha-1-proteinase inhibitor |
| 04/05/1983 | US4379085 Heat stabilization of plasma proteins |
| 04/05/1983 | US4379083 Process for the preparation of blood plasma fractions |
| 04/05/1983 | US4379038 Process for preparing a physiologically active substance controlled release composite composition |
| 04/05/1983 | CA1144160A1 Process for the manufacture of lh-rh and lh-rh analogs using glu-his(dnp)-oh |
| 03/31/1983 | WO1983001074A1 Enzymatic preparation of human insulin or b-30 esters thereof |
| 03/31/1983 | WO1983001062A1 Antigenic peptide compound |
| 03/30/1983 | EP0075444A2 Methods and products for facile microbial expression of DNA sequences |
| 03/29/1983 | US4378373 Derivatives of benzoylphenoxyalkanoic acids having normolipemizing activity |
| 03/29/1983 | US4378347 Composition for treating the heart for myocardial infarction |
| 03/29/1983 | US4378346 Contacting with silicon dioxide |
| 03/29/1983 | CA1143656A1 Liposome including active substance |
| 03/23/1983 | EP0074787A1 Renally active dipeptides |
| 03/23/1983 | EP0074712A1 Pharmacologically active naphthotriazole derivatives |
| 03/22/1983 | US4377574 Oligopeptide; antigonadotropin |
| 03/22/1983 | US4377573 Direct injection of a vasoconstrictor |
| 03/22/1983 | US4377572 Tissue adhesive |
| 03/22/1983 | US4377567 To the liver, digalactosyl diglyceride |
| 03/22/1983 | US4377515 Long lasting agonists and antagonists of LH-RH |
| 03/22/1983 | US4377513 Culturing lymph cells in host animals |
| 03/22/1983 | US4377512 Oxygen carrier for blood substitute |
| 03/22/1983 | US4377511 Preparation for control of T-system of immunity and method for producing same |
| 03/22/1983 | CA1143289A1 Microparticle drug delivery system |
| 03/22/1983 | CA1143286A1 Process for obtaining human relaxin |
| 03/17/1983 | WO1983000930A1 Lipoprotein lipase suppression by endotoxin-induce mediator (shock assay) |
| 03/17/1983 | WO1983000929A1 Diagnosis and treatment of parasites |
| 03/17/1983 | WO1983000897A1 Combination lock, particularly for a safe |
| 03/17/1983 | WO1983000860A1 Oligopeptidic ester and amide n-[n'-(2-chlorethyl)-n'-nitroso-carbomoyl] and production method thereof |
| 03/17/1983 | WO1983000810A1 Selective carcinostatic agent |
| 03/16/1983 | EP0074279A2 Selective anti-tumour agents |
| 03/16/1983 | EP0074251A1 Novel lipid fraction, its preparation and pharmaceutical compositions containing same |
| 03/16/1983 | EP0074248A2 Vaccine for hepatitis |
| 03/16/1983 | EP0074240A2 Antibodies specific to endotoxins |
| 03/16/1983 | EP0074103A1 N-(N'-(2-chloroethyl)-N'-nitroso-carbamoyl)-oligopeptide esters and amides, and process for preparing them |
| 03/15/1983 | US4376821 Production of human IFN-gamma (immune) interferon |
| 03/15/1983 | US4376766 Lysine peptides |
| 03/15/1983 | US4376760 Tridecapeptide |
| 03/15/1983 | CA1142853A1 Disaggregated solutions of polypeptides |
| 03/09/1983 | EP0073646A2 Construction of DNA sequences and their use for microbial production of proteins, in particular human serum albumin |
| 03/09/1983 | EP0073616A2 Marine organism extracts, their extraction and use |
| 03/09/1983 | EP0073514A1 Creatinine antibody |
| 03/09/1983 | EP0073251A1 Agent for treating diseases of respiratory organs |
| 03/09/1983 | EP0073210A1 Caries inhibition. |
| 03/08/1983 | US4376059 Process for preparing artificial red cells |
| 03/08/1983 | CA1142621A1 Apparatus for remote temperature reading |
| 03/08/1983 | CA1142514A1 Pharmacologically active peptides |
| 03/08/1983 | CA1142433A1 Medicinally useful, shaped mass of collagen resorbable in the body |
| 03/08/1983 | CA1142431A1 Virus-inactivated hgi-glycoprotein capable of stimulating proliferation and differentiation of human granulocyte, for preparing same and leukopenia curative containing same |
| 03/08/1983 | CA1142430A1 Bone substitute material and its use |
| 03/03/1983 | WO1983000693A1 SUBJECTS RELATING TO HUMAN INTEFERON- alpha SUBTYPE PROTEINS AND CORRESPONDING ANTIBODIES |
| 03/02/1983 | EP0073173A1 Products extracted from invertebrate sea-animals, their preparation and their uses in dietetics,pharmaceutics and cosmetology |
| 03/02/1983 | EP0073143A2 Novel complex amido and imido derivatives of carboxyalkyl peptides and thioethers and ethers of peptides |
| 03/02/1983 | EP0072947A2 Agent for the prevention and treatment of liver diseases |
| 03/01/1983 | US4375513 Bactericides, antibiotic a-4696 |
| 03/01/1983 | US4375414 Immunological methods for removing species from the blood circulatory system and devices therefor |
| 03/01/1983 | CA1142175A1 Fractionation of protein mixtures by salting out followed by dialysis treatment |
| 03/01/1983 | CA1142089A1 Fat emulsion for intravenous injection |
| 03/01/1983 | CA1142085A1 Lipid membrane drug delivery |
| 03/01/1983 | CA1142083A1 Process for the isolation of membrane proteins from neisseria meningitidis and vaccines containing same |
| 03/01/1983 | CA1142082A1 Process for the production of pancreatin pellets |
| 02/23/1983 | EP0072780A1 Imidyl compounds, polymers thereof and the use of the polymers |
| 02/23/1983 | EP0072541A2 Human leukocyte interferons, process for their microbial production, intermediates therefor and compositions containing them |
| 02/22/1983 | US4374928 Novel reductase |
| 02/22/1983 | US4374926 Method for the production of improved chymopapain |
| 02/22/1983 | US4374830 Platelet aggregating material from equine arterial tissue |
| 02/22/1983 | US4374829 Aminoacid derivatives as antihypertensives |
| 02/22/1983 | US4374765 Pentapeptides |
| 02/22/1983 | US4374764 Macrolide antibiotic |
| 02/17/1983 | WO1983000504A1 Enzymatic preparation of human insulin |
| 02/17/1983 | WO1983000444A1 Filtration method for cell produced antiviral substances |
| 02/16/1983 | EP0072352A1 Benzazepin-2-ones, process for their preparation, pharmaceutical preparations containing these compounds and the compounds for therapeutical use |
| 02/16/1983 | EP0071995A2 Fat emulsion for parenteral nutrition |
| 02/16/1983 | EP0071888A2 Process for obtaining sterile solutions of hemoglobin, free of hepatitis, pyrogens and stroma |
| 02/16/1983 | EP0071704A2 Multiple-surface systems for fixing substrates having nucleophilic groups |
| 02/15/1983 | US4374197 Process for thymosin α1 |
| 02/15/1983 | US4374060 Process for the preparation of cyclic hexapeptide |
| 02/15/1983 | CA1141375A1 Tripeptides and method |
| 02/15/1983 | CA1141299A1 Biotin antagonists for dental health-care |
| 02/09/1983 | EP0071544A1 Phosphonamidate compounds |
| 02/09/1983 | EP0071485A2 Novel microorganisms derived from microorganisms of the genus Escherichia by mutation and their use in the preparation of glutathione |
| 02/09/1983 | EP0071433A1 Medicine for the treatment of diabetes |
| 02/09/1983 | EP0071357A1 Pharmaceutical and dietary composition when used for enhancement of 1-series PG production |
| 02/08/1983 | US4372884 Pharmaceutically active peptides |
| 02/08/1983 | CA1140842A1 Method of stabilizing peroxidase in a serum protein based medium |